Elevated Lp(a) Levels Linked To Greater Subclinical Interstitial Myocardial Fibrosis, Analysis Finds

TCTMD (12/13, L. Maxwell) reports, “Elevated levels of lipoprotein(a) seem to be associated with greater subclinical interstitial myocardial fibrosis, increased myocardial scar prevalence, and left atrial remodeling by cardiac magnetic resonance, according to a new analysis.” The notion “that an elevated blood marker might be linked to fibrosis formation opens the door to potentially using Lp(a) to guide and develop treatment strategies for” patients with heart failure, “especially those who have heart failure with preserved ejection fraction, according to the authors.” The findings were published in the Journal of the American College of Cardiology.